Log in
Enquire now

List of Mirror Biologics, Inc. patents

List of Mirror Biologics, Inc. patents
List of Apstra patents
List of KT Corporation patents
List of Myriad Genetics patents
List of companies in ROK Capital's investment portfolio
List of SBIR/STTR awards granted to BIOSENSING INSTRUMENT INC
Patents where
Current Assignee
Name
is
Mirror Biologics, Inc.Mirror Biologics, Inc.
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11648273 Methods for handling biological drugs containing living cells

Patent 11648273 was granted and assigned to Mirror Biologics, Inc. on May, 2023 by the United States Patent and Trademark Office.

Mirror Biologics, Inc.
Mirror Biologics, Inc.
Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11648273
May 16, 2023
‌
US Patent 11037087 Automated device for biologic drug distribution

Patent 11037087 was granted and assigned to Mirror Biologics, Inc. on June, 2021 by the United States Patent and Trademark Office.

Immunovative Therapies
Immunovative Therapies
Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11037087
June 15, 2021
‌
US Patent 11213576 Vaccine comprising allogeneic T-cells

Patent 11213576 was granted and assigned to Mirror Biologics, Inc. on January, 2022 by the United States Patent and Trademark Office.

Mirror Biologics, Inc.
Mirror Biologics, Inc.
Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11213576
January 4, 2022
‌
US Patent 11045541 Allogeneic T-cell compositions for induction of IL-12

Patent 11045541 was granted and assigned to Mirror Biologics, Inc. on June, 2021 by the United States Patent and Trademark Office.

Immunovative Therapies
Immunovative Therapies
Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11045541
June 29, 2021
‌
US Patent 10729754 Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome

Patent 10729754 was granted and assigned to Mirror Biologics, Inc. on August, 2020 by the United States Patent and Trademark Office.

Immunovative Therapies
Immunovative Therapies
Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
10729754
August 4, 2020
‌
US Patent 10548956 Allogeneic cellular immunotherapy for opportunistic infection

Patent 10548956 was granted and assigned to Mirror Biologics, Inc. on February, 2020 by the United States Patent and Trademark Office.

Immunovative Therapies
Immunovative Therapies
Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
10548956
February 4, 2020
‌
US Patent 11160852 Method of vaccinating using allogeneic cells

Patent 11160852 was granted and assigned to Mirror Biologics, Inc. on November, 2021 by the United States Patent and Trademark Office.

Mirror Biologics, Inc.
Mirror Biologics, Inc.
Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11160852
November 2, 2021
‌
US Patent 10744158 Th1 vaccination priming for active immunotherapy

Immunovative Therapies
Immunovative Therapies
Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
10744158
August 18, 2020
‌
US Patent 10751372 Vaccine compositions and methods

Immunovative Therapies
Immunovative Therapies
Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
10751372
August 25, 2020
‌
US Patent 10806777 Method for allogeneic cell therapy

Patent 10806777 was granted and assigned to Mirror Biologics, Inc. on October, 2020 by the United States Patent and Trademark Office.

Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
10806777
October 20, 2020
‌
US Patent 11833173 Th1 vaccination priming for active immunotherapy

Patent 11833173 was granted and assigned to Mirror Biologics, Inc. on December, 2023 by the United States Patent and Trademark Office.

Mirror Biologics, Inc.
Mirror Biologics, Inc.
Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11833173
December 5, 2023
‌
US Patent 11883490 Induction of IL-12 using immunotherapy

Patent 11883490 was granted and assigned to Mirror Biologics, Inc. on January, 2024 by the United States Patent and Trademark Office.

Mirror Biologics, Inc.
Mirror Biologics, Inc.
Mirror Biologics, Inc.
Mirror Biologics, Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11883490
January 30, 2024
12 results
0 selected
12 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us